Culture change from below is the only way to overcome poverty, says Leopold Scholtz.
After the tech euphoria of 2013, the fast-moving sector has hit a speed bump.
Changing the money creation system may be simpler than we think, says Edward Ingram.
Novartis and GlaxoSmithKline have agreed to trade more than $20bn worth of assets to bolster their best businesses and exit weaker ones.
Shares in European drugmakers received a shot in the arm amid a flurry of activity.
Swiss drugmaker Novartis is transforming its business by exchanging certain
assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly
A report says Pfizer may come back to bid for British drug company AstraZeneca after an earlier takeover approach was rejected.
Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as it seeks to build a new sales model.
GlaxoSmithKline is facing a criminal investigation in Poland for allegedly
bribing doctors to promote its lung drug Seretide.
Investors are confident that Sun Pharma's $3.2bn purchase of rival Ranbaxy is a great deal, banking on Sun's history of nursing ailing companies back to health.
Governments who stockpile Roche's flu medicine Tamiflu are wasting billions on a drug whose effectiveness is in doubt, researchers say.
Resolutions have been passed at an extraordinary general meeting of Adcock Ingram shareholders to appoint three new board members.
The World Health Organisation wants a "concerted effort" to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus.
Sun Pharma has announced a $3.2bn deal to buy the larger and troubled Ranbaxy from Daiichi Sankyo, ending the Japanese company's costly run as owner.
A Fin24 user wants to know the tax implications of becoming an independent contractor.
Debt hunger has become stronger even as many people face insolvency, says an expert.
Help us help you by taking our second annual Debt survey and you could win R3 000!
Taxpayers must ensure their Sars affairs are in order.
Advice for a Fin24 user on how to deal with an incompetent debt counsellor.
A user has observed shrinkflation since the1970s and says it's nothing new.
A Fin24 user overcame his unemployment crisis by taking matters into his own hands.
Advice for a user who is battling with clients paying late or withholding payment.
Indian drug company Biocon has rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for a diabetes drug.
Shares in Adcock Ingram hardly moved after naming industry newcomer Kevin Wakeford as its new chief executive.
President of the Cope Youth Movement, Abel Rangata, and three other Cope members have resigned from the party to join the ANC.
Yes, the miners are suffering
No, the miners were exploited long enough
A pay hike won't resolve mining sector ills
Previous results ·
Suggest a vote
Get your financial questions answered.
News delivered really simply.
Easy-to-use personal finance tools.
You choose what you want.
Your opinion on you, me and everyone.
Get us in your home, on your television.
Lost? Confused? Problems? Let us help you.